These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 11464621

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
    Iwamoto J, Saito Y, Honda A, Matsuzaki Y.
    World J Gastroenterol; 2013 Mar 21; 19(11):1673-82. PubMed ID: 23555156
    [Abstract] [Full Text] [Related]

  • 23. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP.
    Gastroenterol Hepatol; 2005 Nov 21; 28(9):567-75. PubMed ID: 16277966
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
    Dobrilla G, Piazzi L, Amplatz S, Benvenuti S, Di Fede F.
    Ital J Gastroenterol; 1992 Feb 21; 24(2):79-84. PubMed ID: 1576367
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
    Ramsoekh D, van Leerdam ME, Rauws EA, Tytgat GN.
    Clin Gastroenterol Hepatol; 2005 Sep 21; 3(9):859-64. PubMed ID: 16234022
    [Abstract] [Full Text] [Related]

  • 29. Gastro-duodenal disease in Africa: Literature review and clinical data from Accra, Ghana.
    Archampong TN, Asmah RH, Richards CJ, Martin VJ, Bayliss CD, Botão E, David L, Beleza S, Carrilho C.
    World J Gastroenterol; 2019 Jul 14; 25(26):3344-3358. PubMed ID: 31341360
    [Abstract] [Full Text] [Related]

  • 30. Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.
    Jainan W, Vilaichone RK.
    Asian Pac J Cancer Prev; 2014 Jul 14; 15(24):10957-60. PubMed ID: 25605208
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Jul 14; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 36. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM, Kim N, Lee BH, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS.
    Scand J Gastroenterol; 2011 Nov 14; 46(11):1295-301. PubMed ID: 21815866
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The role of Helicobacter pylori in the etiology of peptic ulcer and its therapy].
    Köksal H.
    Mikrobiyol Bul; 1993 Jul 14; 27(3):266-70. PubMed ID: 8361417
    [Abstract] [Full Text] [Related]

  • 40. Differences in peptic ulcer between the East and the West.
    Leong RW.
    Gastroenterol Clin North Am; 2009 Jun 14; 38(2):363-79. PubMed ID: 19446264
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.